The assessment of the impact of antiepileptic drugs on cognitive functions via n-200/p-300 potentials and neuropsychological measures

HIGHLIGHTS

• What: The aim of this study was to demonstrate potential changes in cognitive functions in patients diagnosed with from both neuropsychological and electrophysiological perspectives. Statistically significant differences were observed between the healthy control group and the group in terms of average Montreal Cognitive Assessment (MoCA) scores and_(ERPs) (n200 p300 latencies n2p3 Conclusions This study demonstrated the detrimental effects of certain ASMs particularly topiramate and carbamazepine on cognitive functions. By defining these inclusion and exclusion criteria, the study aimed to ensure that participants fell within a specific age range and possessed a confirmed diagnosis of epilepsy. The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.